Your browser doesn't support javascript.
loading
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.
Ishikawa, Yuki; Tanaka, Nao; Asano, Yoshihide; Kodera, Masanari; Shirai, Yuichiro; Akahoshi, Mitsuteru; Hasegawa, Minoru; Matsushita, Takashi; Saito, Kazuyoshi; Motegi, Sei-Ichiro; Yoshifuji, Hajime; Yoshizaki, Ayumi; Kohmoto, Tomohiro; Takagi, Kae; Oka, Akira; Kanda, Miho; Tanaka, Yoshihito; Ito, Yumi; Nakano, Kazuhisa; Kasamatsu, Hiroshi; Utsunomiya, Akira; Sekiguchi, Akiko; Niiro, Hiroaki; Jinnin, Masatoshi; Makino, Katsunari; Makino, Takamitsu; Ihn, Hironobu; Yamamoto, Motohisa; Suzuki, Chisako; Takahashi, Hiroki; Nishida, Emi; Morita, Akimichi; Yamamoto, Toshiyuki; Fujimoto, Manabu; Kondo, Yuya; Goto, Daisuke; Sumida, Takayuki; Ayuzawa, Naho; Yanagida, Hidetoshi; Horita, Tetsuya; Atsumi, Tatsuya; Endo, Hirahito; Shima, Yoshihito; Kumanogoh, Atsushi; Hirata, Jun; Otomo, Nao; Suetsugu, Hiroyuki; Koike, Yoshinao; Tomizuka, Kohei; Yoshino, Soichiro.
Afiliação
  • Ishikawa Y; RIKEN Center for Integrative Medical Sciences, The Laboratory for Statistical and Translational Genetics, Yokohama, Japan.
  • Tanaka N; RIKEN Center for Integrative Medical Sciences, The Laboratory for Statistical and Translational Genetics, Yokohama, Japan.
  • Asano Y; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kodera M; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Shirai Y; Department of Dermatology, The University of Tokyo, Tokyo, Japan.
  • Akahoshi M; Department of Dermatology, Chukyo Hospital, Japan Community Health Care Organization, Nagoya, Japan.
  • Hasegawa M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Matsushita T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Saito K; Department of Rheumatology, Saga University Hospital, Saga, Japan.
  • Motegi SI; Faculty of Medical Sciences, Department of Dermatology, University of Fukui, Fukui, Japan.
  • Yoshifuji H; Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Yoshizaki A; The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Kohmoto T; Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Takagi K; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Oka A; Department of Dermatology, The University of Tokyo, Tokyo, Japan.
  • Kanda M; Aichi Cancer Center Research Institute, Division of Molecular Genetics, Nagoya, Japan.
  • Tanaka Y; Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.
  • Ito Y; Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Nakano K; Department of Dermatology, Chukyo Hospital, Japan Community Health Care Organization, Nagoya, Japan.
  • Kasamatsu H; Department of Dermatology, Chukyo Hospital, Japan Community Health Care Organization, Nagoya, Japan.
  • Utsunomiya A; Department of Dermatology, Chukyo Hospital, Japan Community Health Care Organization, Nagoya, Japan.
  • Sekiguchi A; The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Niiro H; Faculty of Medical Sciences, Department of Dermatology, University of Fukui, Fukui, Japan.
  • Jinnin M; Faculty of Medical Sciences, Department of Dermatology, University of Fukui, Fukui, Japan.
  • Makino K; Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Makino T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Ihn H; Department of Dermatology, Wakayama Medical University Graduate School of Medicine, Wakayama, Japan.
  • Yamamoto M; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Suzuki C; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Takahashi H; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Nishida E; Department of Rheumatology and Allergy, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Morita A; Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Yamamoto T; Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Fujimoto M; Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kondo Y; Department of Dermatology, Okazaki City Hospital, Okazaki, Japan.
  • Goto D; Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Sumida T; Department of Dermatology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
  • Ayuzawa N; Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Yanagida H; Department of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Horita T; Department of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Atsumi T; Department of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Endo H; Department of Clinical Immunology, National Hospital Organization, Utano National Hospital, Kyoto, Japan.
  • Shima Y; Department of Clinical Immunology, National Hospital Organization, Utano National Hospital, Kyoto, Japan.
  • Kumanogoh A; Faculty of Medicine and Graduate School of Medicine, Department of Rheumatology, Endocrinology and Nephrology, Hokkaido University, Sapporo, Japan.
  • Hirata J; Faculty of Medicine and Graduate School of Medicine, Department of Rheumatology, Endocrinology and Nephrology, Hokkaido University, Sapporo, Japan.
  • Otomo N; Omori Medical Center, Toho University, Rheumatic Disease Center, Tokyo, Japan.
  • Suetsugu H; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Koike Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tomizuka K; Immunology Frontier Center, Osaka University, Statistical Immunology, Osaka, Japan.
  • Yoshino S; RIKEN Center for Integrative Medical Sciences, The Laboratory for Statistical and Translational Genetics, Yokohama, Japan.
Nat Commun ; 15(1): 319, 2024 Jan 31.
Article em En | MEDLINE | ID: mdl-38296975
ABSTRACT
Here we report the largest Asian genome-wide association study (GWAS) for systemic sclerosis performed to date, based on data from Japanese subjects and comprising of 1428 cases and 112,599 controls. The lead SNP is in the FCGR/FCRL region, which shows a penetrating association in the Asian population, while a complete linkage disequilibrium SNP, rs10917688, is found in a cis-regulatory element for IRF8. IRF8 is also a significant locus in European GWAS for systemic sclerosis, but rs10917688 only shows an association in the presence of the risk allele of IRF8 in the Japanese population. Further analysis shows that rs10917688 is marked with H3K4me1 in primary B cells. A meta-analysis with a European GWAS detects 30 additional significant loci. Polygenic risk scores constructed with the effect sizes of the meta-analysis suggest the potential portability of genetic associations beyond populations. Prioritizing the top 5% of SNPs of IRF8 binding sites in B cells improves the fitting of the polygenic risk scores, underscoring the roles of B cells and IRF8 in the development of systemic sclerosis. The results also suggest that systemic sclerosis shares a common genetic architecture across populations.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Predisposição Genética para Doença Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Predisposição Genética para Doença Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão